Your browser is no longer supported. Please, upgrade your browser.
PTI Proteostasis Therapeutics, Inc. daily Stock Chart
Proteostasis Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.76 Insider Own0.90% Shs Outstand50.00M Perf Week7.47%
Market Cap201.50M Forward P/E- EPS next Y-1.80 Insider Trans-1.62% Shs Float41.68M Perf Month29.17%
Income-58.40M PEG- EPS next Q-0.43 Inst Own71.70% Short Float8.27% Perf Quarter-35.31%
Sales4.50M P/S44.78 EPS this Y-13.60% Inst Trans49.39% Short Ratio3.19 Perf Half Y71.49%
Book/sh1.06 P/B3.80 EPS next Y-7.80% ROA-76.70% Target Price13.80 Perf Year38.97%
Cash/sh0.93 P/C4.34 EPS next 5Y- ROE-104.10% 52W Range1.71 - 10.38 Perf YTD24.38%
Dividend- P/FCF- EPS past 5Y- ROI-87.20% 52W High-61.18% Beta-
Dividend %- Quick Ratio4.20 Sales past 5Y- Gross Margin- 52W Low135.67% ATR0.33
Employees50 Current Ratio4.20 Sales Q/Q-31.30% Oper. Margin- RSI (14)60.23 Volatility7.92% 9.84%
OptionableYes Debt/Eq0.00 EPS Q/Q9.70% Profit Margin- Rel Volume1.11 Prev Close4.03
ShortableYes LT Debt/Eq0.00 EarningsMar 13 AMC Payout- Avg Volume1.08M Price4.03
Recom1.80 SMA2019.64% SMA5010.65% SMA2008.02% Volume0 Change0.00%
Oct-18-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Dec-12-17Reiterated Robert W. Baird Outperform $13 → $25
Apr-18-16Initiated Guggenheim Neutral
Mar-07-16Initiated Robert W. Baird Outperform $13
Mar-07-16Initiated RBC Capital Mkts Outperform $20
Mar-07-16Initiated Leerink Partners Outperform
Mar-07-16Initiated H.C. Wainwright Buy $15
Feb-20-19 07:00AM  Proteostasis Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-12-19 09:00AM  Biotech Plays in the News You Should Know ACCESSWIRE
Feb-07-19 10:54AM  How Much Of Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Do Institutions Own? Simply Wall St. -5.50%
09:00AM  Biotech Stocks Set to Pop ACCESSWIRE
Feb-06-19 12:15PM  4 Biotech Stocks Making Moves on Wednesday (2/6/19) ACCESSWIRE +5.14%
08:00AM  Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors PR Newswire
Dec-21-18 12:25PM  These 4 Biotech Stocks Are Raising Eyebrows ACCESSWIRE
07:58AM  The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial Benzinga
Dec-20-18 04:30PM  Proteostasis Therapeutics Provides Clinical Enrollment Update PR Newswire -6.38%
10:35AM  How Many Insiders Bought Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Shares? Simply Wall St.
Dec-19-18 08:50AM  Implied Volatility Surging for Proteostasis Therapeutics (PTI) Stock Options Zacks
05:37AM  Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't American City Business Journals
Dec-17-18 02:09PM  This Week's Top Tech Earnings and Today's Trending Stocks: PTI & NBEV Zacks -7.07%
12:53PM  Biotech News: Proteostasis Therapeutics (PTI) Stock Soars on Genentech InvestorPlace
09:54AM  Proteostasis Therapeutics Rallies On Genentech Licensing Agreement Benzinga
07:00AM  Proteostasis Therapeutics Announces Global License Agreement with Genentech PR Newswire
Nov-28-18 08:41AM  Vertex's (VRTX) Triple Combo Cystic Fibrosis Studies Succeed Zacks +9.22%
Nov-21-18 07:00AM  Proteostasis Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Nov-19-18 08:39AM  Is the Options Market Predicting a Spike in Proteostasis Therapeutics (PTI) Stock? Zacks
Nov-12-18 03:25PM  Proteostasis Therapeutics (PTI) Reports Q3 Loss, Tops Revenue Estimates Zacks -5.98%
Nov-06-18 10:30AM  Will Proteostasis Therapeutics (PTI) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-26-18 09:15AM  Consolidated Research: 2018 Summary Expectations for Lexington Realty Trust, Proteostasis Therapeutics, PDC Energy, Twenty-First Century Fox, Square, and Sabra Healthcare REIT Fundamental Analysis, Key Performance Indications GlobeNewswire +11.96%
Oct-23-18 07:25PM  Proteostasis Therapeutics Prices Public Offering of Common Stock PR Newswire
08:35AM  The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares Benzinga
Oct-22-18 04:01PM  Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire -9.43%
01:56PM  5 Low-Priced Biotech Stocks to Take Advantage of the Market Rout InvestorPlace
Oct-19-18 05:41PM  Why Proteostasis Therapeutics Tumbled 23.2% on Friday Motley Fool -23.19%
03:20PM  Is Proteostasis Therapeutics Inc (NASDAQ:PTI) Worth US$10.35 Based On Intrinsic Value? Simply Wall St.
08:00AM  Todays Research Reports on Stocks to Watch: Proteostasis Therapeutics and Endocyte ACCESSWIRE
Oct-18-18 12:13PM  PTI Stock News: Why Is Proteostasis Therapeutics Stock Skyrocketing Today InvestorPlace +447.62%
11:15AM  Proteostasis Therapeutics Shares Surge On Positive Preliminary Cystic Fibrosis Trial Results Benzinga
10:57AM  Proteostasis Therapeutics' rockets to 4-fold gain on massive volume after positive trial results MarketWatch
07:56AM  The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs Benzinga
Oct-17-18 04:05PM  Proteostasis Therapeutics Announces Positive Preliminary Results from Proprietary Doublet in Cystic Fibrosis Patients PR Newswire
Oct-05-18 08:33AM  Implied Volatility Surging for Proteostasis Therapeutics (PTI) Stock Options Zacks
Sep-28-18 07:30AM  Report: Exploring Fundamental Drivers Behind Ares Commercial Real Estate, Proteostasis Therapeutics, SunCoke Energy Partners, Fastenal, CNA Financial, and City Office REIT New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Sep-27-18 07:00AM  Proteostasis Therapeutics to Present at the Cantor Global Healthcare Conference PR Newswire -8.96%
Jun-25-18 07:00AM  Proteostasis Added to the Russell 3000® Index PR Newswire
Jun-08-18 08:00AM  Todays Research Reports on Stocks to Watch: Proteostasis Therapeutics and Ophthotech Corporation ACCESSWIRE
07:50AM  Proteostasis Therapeutics (PTI) Enters Oversold Territory Zacks
07:35AM  Analysis: Positioning to Benefit within Proteostasis Therapeutics, Yum China, Pretium Resources, Lexington Realty Trust, AngloGold Ashanti, and New Gold Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-07-18 04:52PM  More Data Needed On Proteostasis Therapeutics' Cystic Fibrosis Candidate, RBC Says In Downgrade Benzinga -38.16%
Jun-06-18 04:05PM  Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy PR Newswire
Jun-04-18 07:20AM  Initiating Free Research Reports on Pulmatrix and Three Other Biotech Equities ACCESSWIRE
Jun-01-18 07:00AM  Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference PR Newswire
May-31-18 07:00AM  Proteostasis Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference PR Newswire
May-08-18 07:00AM  Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis PR Newswire
Apr-24-18 12:32PM  Lifshitz & Miller LLP Announces Investigation of Acadia Pharmaceuticals Inc., Allegiant Travel Company, Camping World Holdings, Inc., Finish Line, Inc., Myriad Genetics, Inc., Proteostasis Therapeutics, Inc., Under Armour, Inc. and United Community Bancorp PR Newswire
Apr-17-18 07:10AM  Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko Therapy PR Newswire
Apr-16-18 08:40AM  Is the Options Market Predicting a Spike in Proteostasis Therapeutics (PTI) Stock? Zacks
Apr-06-18 07:00AM  Blog Exposure - FDA Granted Fast Track Designation to Proteostasis Therapeutics Triple Combination Program for Cystic Fibrosis ACCESSWIRE
Apr-04-18 08:29AM  Proteostasis shares surge 12% on FDA 'fast track' designation for cystic fibrosis treatment MarketWatch +6.52%
06:00AM  Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis PR Newswire
Apr-03-18 07:30PM  PTI INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Proteostasis Therapeutics, Inc. Investors Business Wire -5.12%
Mar-27-18 08:20AM  Consolidated Research: 2018 Summary Expectations for TE Connectivity, CNH Industrial N.V., Proteostasis Therapeutics, Qudian Inc. Sponsored ADR, Arcos Dorados, and Crescent Point Energy Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-22-18 04:47PM  PROTEOSTASIS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Proteostasis Therapeutics, Inc. To Contact The Firm PR Newswire
10:30AM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Proteostasis Therapeutics, Inc. Investors (PTI) Business Wire
Mar-21-18 04:29PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Proteostasis Therapeutics, Inc. Investors (PTI) Business Wire +6.01%
04:06PM  Bragar Eagel & Squire, P.C. is Investigating Proteostasis Therapeutics, Inc. (PTI) on Behalf of Stockholders and Encourages Investors to Contact the Firm Business Wire
12:30PM  Scott+Scott Attorneys at Law LLP Announces Investigation into Proteostasis Therapeutics, Inc. (PTI) PR Newswire
09:06AM  Proteostasis won't complete public offering after short report; shares rise 14% MarketWatch
08:03AM  Benzinga Pro's 6 Stocks To Watch Today Benzinga
06:58AM  ICYMI: Proteostasis Bear Call, eSports, Oracle's Q3, Roku Interview Benzinga
Mar-20-18 07:59PM  Proteostasis Therapeutics Announces Withdrawal of Equity Offering Due to Market Conditions PR Newswire -26.18%
01:32PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Proteostasis Therapeutics, Inc. - PTI PR Newswire
12:51PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Proteostasis Therapeutics, Inc. (PTI) PR Newswire
11:41AM  Biotech short seller eviscerates Proteostasis in new report, dinging shares American City Business Journals
10:19AM  Proteostasis Therapeutics shares tank 18% after Kerrisdale Capital puts out short report MarketWatch
08:02AM  Benzinga Pro's 6 Stocks To Watch Today Benzinga
Mar-19-18 04:01PM  Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock PR Newswire
Mar-16-18 02:33PM  The Week Ahead In Biotech: Earnings, PDUFA Dates And More Benzinga
10:59AM  Baird: Prospects For Proteostasis Therapeutics' PTI-428 Are Not Priced Into The Stock Benzinga
08:37AM  Proteostasis Therapeutics (PTI) Looks Good: Stock Adds 8% in Session Zacks
Mar-15-18 12:06PM  Did Insiders Buy On Proteostasis Therapeutics Incs (NASDAQ:PTI) Price Volatility? Simply Wall St. +8.01%
08:49AM  Proteostasis stock rises 22% on FDA designation, smaller-than-expected Q4 loss MarketWatch
08:25AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
05:03AM  Proteostasis reports 4Q loss Associated Press
Mar-14-18 05:29PM  Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update GlobeNewswire
04:30PM  Proteostasis Therapeutics Announces FDA Grants Orphan Drug Designation for PTI-428 in Cystic Fibrosis GlobeNewswire
Mar-13-18 01:20PM  Proteostasis Therapeutics Inc (PTI) Soars on Cystic Fibrosis Approval InvestorPlace +54.11%
10:16AM  Proteostasis's stock rockets on heavy volume after BTD granted MarketWatch
08:12AM  Benzinga Pro's 5 Stock To Watch Today Benzinga
Mar-12-18 04:05PM  Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis GlobeNewswire
Mar-07-18 07:00AM  Proteostasis Therapeutics to Present at the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-08-18 07:00AM  Proteostasis Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference GlobeNewswire -6.79%
Jan-08-18 07:00AM  Proteostasis Proprietary Triple Combination Therapy Study Protocol Receives Endorsement and High Strategic Fit Score from the Largest Cystic Fibrosis Patient Advocacy Groups in the U.S. and Europe GlobeNewswire -6.87%
Dec-26-17 12:00PM  ETFs with exposure to Proteostasis Therapeutics, Inc. : December 26, 2017 Capital Cube +5.76%
Dec-21-17 04:50PM  Proteostasis Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Dec-19-17 09:15AM  Proteostasis Therapeutics Inc (PTI) President and CEO Meenu Chhabra Bought $200,000 of Shares +12.30%
Dec-15-17 10:00AM  Proteostasis Therapeutics, Inc. (Nasdaq:PTI) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire +6.40%
Dec-13-17 09:24AM  Proteostasis Stock Surges on Positive Data From CF Studies Zacks -10.91%
08:05AM  Proteostasis Soars on News of Positive Trial Results, Baird Says Outperform ACCESSWIRE
Dec-12-17 04:24PM  Proteostasis Therapeutics shares down 8% after proposed share offering MarketWatch +161.28%
02:00PM  ETFs with exposure to Proteostasis Therapeutics, Inc. : December 12, 2017 Capital Cube
01:11PM  Proteostasis Therapeutics Inc (PTI) Is Blasting Off 165% Following Three Clinical Wins in Cystic Fibrosis SmarterAnalyst
07:29AM  Proteostasis Therapeutics' stock nearly doubles on heavy volume after positive trial results MarketWatch
Dec-11-17 04:21PM  Proteostasis Therapeutics Announces Positive Clinical Results from Studies of PTI-428, PTI-801 and PTI-808 in Healthy Volunteers and Patients with Cystic Fibrosis GlobeNewswire
Nov-29-17 08:49AM  Proteostasis Therapeutics, Inc. :PTI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube +32.14%
Nov-16-17 05:14AM  Proteostasis reports 3Q loss Associated Press
Nov-14-17 05:40PM  Proteostasis Therapeutics Reports Third Quarter 2017 Results and Provides CF Portfolio Update GlobeNewswire
Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers and develops novel therapeutics to treat cystic fibrosis and other diseases caused by an imbalance in the proteostasis network. Its lead product candidate is PTI-428, an orally bioavailable cystic fibrosis transmembrane conductance regulator modulator belonging to the amplifier class, which is in Phase II study. The company is also involved in developing PTI-801, a corrector molecule; and PTI-808, a potentiator molecule that have been completed Phase I Study. It has a collaboration agreement with Astellas Pharma Inc. Astellas Pharma, Inc. to research and identify therapies targeting the UPR pathway. The company was formerly known as Proteoguard, Inc. and changed its name to Proteostasis Therapeutics, Inc. in September 2007. Proteostasis Therapeutics, Inc. was founded in 2006 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Munoz BenitoChief Scientific OfficerFeb 04Sale2.999,51428,45415,439Feb 05 08:04 PM
Lee Po ShunSee RemarksFeb 04Sale2.999,93129,70018,427Feb 05 08:00 PM
Gilmartin Geoffrey S.Chief Development OfficerFeb 04Sale2.999,18927,48014,911Feb 05 07:59 PM
Chhabra MeenuPresident and CEOFeb 04Sale2.9916,47849,30580,615Feb 05 07:57 PM
Lee Po ShunSee RemarksJan 29Sale3.007122,1362,312Jan 30 04:29 PM
Lee Po ShunSee RemarksJan 28Sale3.001,6004,8003,024Jan 30 04:29 PM
BERGER FRANKLIN MDirectorOct 26Buy6.7540,000270,00040,000Oct 26 04:16 PM